Skip to content
Est. 1998 proudly celebrating our 27th year of championing American business
American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

BeyondSpring Inc.

$1.70 -0.58% NASDAQ: BYSI · 15-min delayed
  • FLORHAM PARK, New Jersey
  • Public · NASDAQ: BYSI
  • 44 employees
$70.3MMarket cap
$0Revenue · FY2017
-$1.0MNet income
44Employees
BYSINASDAQ
2017IPO

About BeyondSpring Inc.

BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It operates in Plinabulin pipeline segment. Its first asset, Plinabulin is a novel brain-penetrant microtubule modulator with dendritic cell maturation and vasculature modulation mechanism, which has the potential to help mitigate acquired resistance from prior immune checkpoint inhibitors (ICI) treatment in cancer patients. It is a Selective Immunomodulating Microtubule-Binding Agent (SIMBA), which may provide multiple therapeutic opportunities.

This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.

Reported figures

Financial summary

Revenue FY2017
$0
Net income
-$1.0M
Total assets
$25.9M
Market cap
$70.3M

Source: SEC EDGAR · updated Jun 7, 2026

Multi-year

Revenue & profit trend

Revenue Net income
FY 2025

Financial statements

Income statement

Revenue
$0
Operating income
-$8.9M
Income tax
$90.0K
Net income
-$14.2M
EPS (basic)
$-0.02

Balance sheet

Total assets
$25.9M
Current assets
$20.9M
Total liabilities
$49.9M
Current liabilities
$13.6M
Shareholders’ equity
-$24.0M

Cash flow

Operating cash flow
-$19.8M
Investing cash flow
$10.8M
Financing cash flow
$5.0M
Net cash flow
-$4.0M

Statements via Polygon.io (SEC filings)

NASDAQ: BYSI
$1.70 -0.58%

15-minute delayed · data by Polygon.io

Past year

$1.27 $3.40

52-week range

Market cap
$70.3M
Shares outstanding
41.4M
Open
Day range
Prev close
Volume
IPO date
Mar 9, 2017

Market data by Polygon.io · prices are 15-minute delayed

Auto-generated

At a glance

  • Reported a net loss of $1.0M in FY2017.
  • Trading 50% below its 52-week high.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review BeyondSpring Inc..

Write a review
Newsroom

News about BeyondSpring Inc.

News & sentiment via Polygon.io

Explore

Similar companies

Browse all →